## PH: Parker-Hannifin Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.6% below STRENGTH zone (3.0-6.0%); PEG 4.79 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($854.31)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. How Investors May Respond To Parker-Hannifin (PH) Wave Of Reaffirmed Bullish Analyst Ratings**
- Source: Simply Wall Street | 20251221T140836 | Bullish | Relevance: 100%
- Multiple research firms have recently reaffirmed bullish ratings for Parker-Hannifin (PH), signaling strong analyst confidence in the company's operational and earnings outlook. This wave of positive sentiment highlights Parker-Hannifin as a preferred large-cap industrial and aerospace supplier. Investors should consider how this impacts the existing earnings, margin, and valuation narrative, particularly given the company's dividend increase and increasing reliance on aerospace and defense revenue.

**2. How Investors May Respond To Parker-Hannifin (PH) Wave Of Reaffirmed Bullish Analyst Ratings**
- Source: Simply Wall Street | 20251221T113514 | Bullish | Relevance: 100%
- Multiple research firms have recently reiterated positive views on Parker-Hannifin (PH), indicating strong analyst confidence in the company's operational and earnings outlook. This wave of bullish ratings, coupled with a 10% dividend hike, reinforces the investment narrative around its compounding earnings through industrial recovery and aerospace strength. Investors should consider how these factors and the growing reliance on aerospace revenue might influence the company's valuation amidst varying fair value estimates.

**3. Congress Asset Management Co. Has $143.92 Million Position in Parker-Hannifin Corporation $PH**
- Source: MarketBeat | 20251221T093941 | Somewhat-Bullish | Relevance: 100%
- Congress Asset Management Co. reduced its stake in Parker-Hannifin Corporation by 0.7% in the third quarter, now owning 189,825 shares valued at $143.92 million, representing 0.15% of the company. Other institutional investors have also adjusted their positions, and 82.44% of the stock is held by such investors. The article details Parker-Hannifin's recent financial performance, dividend announcement, analyst ratings, and insider trading activity.

**4. Marine Hydraulic Fluid Market Is Going to Boom |• Parker**
- Source: openPR.com | 20251222T140136 | Bullish | Relevance: 100%
- Worldwide Market Reports has published a comprehensive study on the "Marine Hydraulic Fluid Market," predicting substantial growth in the coming years. The report offers an in-depth analysis of market dynamics, competitive landscape, regional outlook, and segmental highlights, supported by extensive primary and secondary research. It aims to provide actionable intelligence and growth forecasts to aid business planning and decision-making for stakeholders.

**5. Here's Why It is Worth Investing in Nordson Stock Right Now**
- Source: TradingView — Track All Markets | 20251222T150918 | Somewhat-Bullish | Relevance: 59%
- Nordson Corporation (NDSN) is a strong investment due to its diversified business, focus on operational excellence, and strategic acquisitions. The company is experiencing growth in its Medical and Fluid Solutions segment and has expanded its medical offerings through the acquisition of Atrion Corp. Nordson also maintains shareholder-friendly policies, including significant dividend payments and share repurchases, and has seen upward revisions in earnings estimates.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Truist Securiti | $1097 | $977 | +12% |
| 2025-12-17 | Goldman Sachs | $1000 | $900 | +11% |
| 2025-12-16 | Stifel | $869 | $850 | +2% |
| 2025-12-08 | Citigroup | $1006 | $960 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Truist Securiti | main | Buy |
| 2025-12-17 | Goldman Sachs | main | Buy |
| 2025-12-16 | Stifel | main | Hold |
| 2025-12-08 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 5 ($3.88M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.1%)
- Blackrock Inc.: 7.8% (+0.6%)
- State Street Corpora: 7.6% (-0.7%)
- Procyon Advisors, LL: 4.0% (+158565.8%)
- Bank of America Corp: 3.1% (+0.6%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-1.7% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $3.9M in recent transactions.
3. Valuation stretched: PEG 4.8x requires aggressive growth execution.

### Catalysts

- Analyst target momentum: 5 raises (avg +7%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.79 signals overvaluation risk, limited margin of safety. Forward P/E 26.8x stretched relative to 9% growth. Quality metrics strong (ROE 27%, margin 18%). Analyst sentiment positive (5 raises, avg +7%). Insider selling cluster ($3.9M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $112.3B |
| Beta | 1.25 |
| 52W Range | $488.45 - $908.35 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.79 |
| Forward P/E | 26.8 |
| Current P/E | 29.3 |
| YoY Growth | 9.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.0% to -0.6% (-1.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.6pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-2.51), momentum weakening. OFD pattern: +DLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.64% (CS: 57) | Neutral |
| RSI_14 | 62.3 | Neutral |
| MACD Histogram | -2.51 | Bearish |
| vs SMA20 | 1.015x | Above |
| vs SMA50 | 1.076x | Above |
| vs SMA200 | 1.235x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $886.71
- **Stop Loss:** $854.31 (3.7% risk)
- **Target:** $919.11 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 27
- **Position Value:** $23,941.17
- **Portfolio %:** 23.94%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-29 (Est: $7.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.62 | $7.22 | +9.0% |
| 2025Q2 | $7.08 | $7.69 | +8.6% |
| 2025Q1 | $6.72 | $6.94 | +3.3% |
| 2024Q4 | $6.23 | $6.53 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*